Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Mol Biol ; 433(18): 167144, 2021 09 03.
Article in English | MEDLINE | ID: mdl-34229012

ABSTRACT

The EphA2 receptor is a promising drug target for cancer treatment, since EphA2 activation can inhibit metastasis and tumor progression. It has been recently described that the TYPE7 peptide activates EphA2 using a novel mechanism that involves binding to the single transmembrane domain of the receptor. TYPE7 is a conditional transmembrane (TM) ligand, which only inserts into membranes at neutral pH in the presence of the TM region of EphA2. However, how membrane interactions can activate EphA2 is not known. We systematically altered the sequence of TYPE7 to identify the binding motif used to activate EphA2. With the resulting six peptides, we performed biophysical and cell migration assays that identified a new potent peptide variant. We also performed a mutational screen that determined the helical interface that mediates dimerization of the TM domain of EphA2 in cells. These results, together with molecular dynamic simulations, allowed to elucidate the molecular mechanism that TYPE7 uses to activate EphA2, where the membrane peptide acts as a molecular clamp that wraps around the TM dimer of the receptor. We propose that this binding mode stabilizes the active conformation of EphA2. Our data, additionally, provide clues into the properties that TM ligands need to have in order to achieve activation of membrane receptors.


Subject(s)
Melanoma/pathology , Membrane Proteins/metabolism , Membranes/metabolism , Peptide Fragments/metabolism , Protein Conformation , Receptor, EphA2/metabolism , Amino Acid Sequence , Binding Sites , Cell Movement , Humans , Ligands , Melanoma/metabolism , Membrane Proteins/chemistry , Membranes/chemistry , Molecular Dynamics Simulation , Peptide Fragments/chemistry , Protein Binding , Protein Domains , Protein Multimerization , Receptor, EphA2/chemistry , Sequence Homology , Tumor Cells, Cultured
2.
Biophys J ; 117(5): 920-929, 2019 09 03.
Article in English | MEDLINE | ID: mdl-31422821

ABSTRACT

The pH-low insertion peptide (pHLIP) is used for targeted delivery of drug cargoes to acidic tissues such as tumors. The extracellular acidosis found in solid tumors triggers pHLIP to transition from a membrane-adsorbed state to fold into a transmembrane α-helix. Different factors influence the acidity required for pHLIP to insert into lipid membranes. One of them is the lipid headgroup composition, which defines the electrostatic profile of the membrane. However, the molecular interactions that drive the adsorption of pHLIP to the bilayer surface are poorly understood. In this study, we combine biophysical experiments and all-atom molecular dynamics simulations to understand the role played by electrostatics in the interaction between pHLIP and a 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine bilayer. We observed that the solution ionic strength affects the structure of pHLIP at the membrane surface as well as the acidity needed for different steps in the membrane insertion process. In particular, our simulations revealed that an increase in ionic strength affected both pHLIP and the bilayer; the coordination of sodium ions with the C-terminus of pHLIP led to localized changes in helicity, whereas the coordination of sodium ions with the phosphate moiety of the phosphocholine headgroups had a condensing effect on our model bilayer. These results are relevant to our understanding of environmental influences on the ability of pHLIP to adsorb to the cell membrane and are useful in our fundamental understanding of the absorption of pH-responsive peptides and cell-penetrating peptides.


Subject(s)
Membrane Lipids/metabolism , Membrane Proteins/metabolism , Ions , Membrane Lipids/chemistry , Membrane Proteins/chemistry , Osmolar Concentration , Phosphatidylcholines/chemistry , Phosphatidylcholines/metabolism , Protein Structure, Secondary , Sodium Chloride
SELECTION OF CITATIONS
SEARCH DETAIL
...